Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
<tr> | <tr> | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
| - | =====[[Peroxisome Proliferator-Activated Receptor]] | + | =====Dipeptidyl Peptidase-4 Inhibitor===== |
| + | * Galvus - Generic: Vildagliptin | ||
| + | * Januvia - Generic: Sitagliptin | ||
| + | * Onglyza - Generic: Saxagliptin | ||
| + | =====[[Peroxisome Proliferator-Activated Receptor]] Agonist===== | ||
* [[Actos]] - Generic: Pioglitazone | * [[Actos]] - Generic: Pioglitazone | ||
* [[Avandia]] - Generic: Rosiglitazone | * [[Avandia]] - Generic: Rosiglitazone | ||
Revision as of 12:53, 6 December 2010
Dipeptidyl Peptidase-4 Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist |
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
